15.286 articles found

Inhibition of synucleinopathic seeding by rationally designed inhibitors.

Sangwan S, Sahay S, Murray KA, Morgan S, Guenther EL, Jiang L, Williams CK, Vinters HV, Goedert M, Eisenberg DS.

Elife · 2020-01-02

DOI: 10.7554/elife.46775PMID: 31895037

Investigation of somatic mutations in synucleinopathies

Leija Salazar MI.

· 2020-01-01

Clinical aspects and in vitro modelling of GBA1 variant-associated Parkinson's disease

Stoker TB.

· 2020-01-01

DOI: 10.17863/cam.49065

Phenotypic analysis of the CRISPR-engineered G51D α-synuclein rat

West SA.

· 2020-01-01

DOI: 10.7488/era/191

Neuroinflammation and alpha-synuclein oligomer toxicity in the pathogenesis of Lewy body dementia and Parkinson's disease

La Vitola P.

· 2020-01-01

DOI: 10.21954/ou.ro.000111c4

Complex trait analysis with a multi-species approach to disentangle genetic modulators of cellular growth phenotypes under disease-relevant treatments

Georghiou D.

· 2020-01-01

DOI: 10.25392/leicester.data.12656717.v1

Genetic analysis of dementia with Lewy bodies

Orme TJ.

· 2020-01-01

The fluid biomarker and genetic determinants of phenotype and survival in progressive supranuclear palsy

Jabbari E.

· 2020-01-01

Mapping networks of alpha-Synuclein proteostasis in cellular models of Parkinson's disease pathology

Lewin R.

· 2020-01-01

Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated mutation of the SNCA gene

Chen Y.

· 2020-01-01

DOI: 10.7488/era/603

Alpha-synuclein and immune system phenotypes in post-mortem human tissue and two prion-like spreading models of Parkinson's disease

Sanchez Garcia S.

· 2020-01-01

Investigating Leucine-rich repeat kinase 2 (LRRK2) function : implications for cellular immune responses

Nazish I.

· 2020-01-01